CTRI/2017/11/010656
Completed
Phase 2
Study of primary hypertension and therapeutic evaluation of sharbat aftimoon in its management.
ational Institute of Unani Medicine0 sites80 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Institute of Unani Medicine
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients with stage\- 1 primary hypertension
- •ranging systolic pressure140 to 159 mmHg and
- •diastolic pressure 90 to 99 mmHg.
- •2\.Patients who will agree to sign the informed
- •consent form and follow up the protocol.
- •3\.Age group: 30 to 65 years.
- •4\.Gender:Either
Exclusion Criteria
- •1\.Patients with cardiac arrhythmias (chronic atrial
- •fibrillation, frequent premature ventricular and
- •atrial contractions, ventricular or
- •supraven¬tricular tachycardia, tachycardia \[heart
- •rate \> 100 beats per minute]), atrioventricular
- •2\.Patients with malignant hypertension.
- •3\.Patients with the episodes of marked arterial
- •hypotension (systolic BP \< 90 mmHg)
- •4\.Patients with the history of myocardial
- •infarction or acute cerebrovascular events,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Treatment of HypertensionCardiovascular DiseasesHeart DiseasesHypertensionVascular DiseasesNCT00000484National Heart, Lung, and Blood Institute (NHLBI)
Completed
Not Applicable
The effects of combined therapy for hypertension on arterial functiohypertension, type 2 diabetes mellitusJPRN-jRCT1091220034Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University60
Active, not recruiting
Not Applicable
The evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment - ACCELERATEAcute hypertension in patients who present with intracerebral hemorrhageMedDRA version: 9.1Level: LLTClassification code 10022754Term: Intracerebral hemorrhageMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2008-000230-53-DEThe Medicines Company60
Completed
Not Applicable
Treatment of Hypertension in Primary Care in SpainHypertensionNCT00868881AstraZeneca2,160
Completed
Not Applicable
Retrospective Survey for Patients With Hypertension and Diabetes MellitusHypertensionNCT00681278AstraZeneca2,000